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Tbjectives: We studied the persistence of favorable outcome, the occurrence of new
trial arrhythmias, and sinus node dysfunction in patients who underwent the maze
II procedure.
ethods: Preoperative, in-hospital, and follow-up data of 203 patients who under-
ent the maze III procedure between June 1993 and June 2003 were collected. A
otal of 139 patients underwent the maze procedure for lone atrial fibrillation, and
4 patients underwent the maze procedure and concomitant cardiac surgery.
esults: There was no 30-day postoperative mortality. During a mean follow-up of
.0  2.6 years, 12 patients (6%) died (2 cardiac related). At the end of follow-up,
reedom from supraventricular arrhythmias was 80% for the lone atrial fibrillation
roup and 64% for the concomitant atrial fibrillation group. Freedom from stroke
uring follow-up was 100% in the lone atrial fibrillation group and 97% in the
oncomitant group. Multivariate analysis revealed that rhythm at 1-year follow-up (P
001; odds ratio 9.56, 95% confidence limits 3.92-23.31) and preoperative left atrium
imension (P  .028; odds ratio 1.06 for every millimeter, 95% confidence limits
.01-1.12) were predictors of success at the end of follow-up.
onclusions: This study shows that the favorable results of the maze III procedure
n terms of freedom from supraventricular arrhythmias persist in most patients for
t least 4 years.
 
he unmodified maze III operation is considered the most successful d
for exclusion, and channeling of left atrial (LA) and right atrial (RA) areas
to eliminate atrial fibrillation (AF) resulting from random reentry or initiated
y rapidly firing foci.1,2 The surgically created pathways preclude AF, prese
inus node function, and maintain atrial contraction and filling in the majority of
atients who undergo the procedure. The avoidance of intraoperative mapping of
trial arrhythmias is a clear advantage.
Since 1990, many reports have addressed the favorable effects of maze III
urgery in patients undergoing concomitant cardiac surgery, predominantly mitral
alve surgery.3-10 However, there are few reports focusing on maze III su
erformed exclusively for symptomatic and drug-refractory AF without detectable
ause (lone AF).4,6,11,12
The results of percutaneous methods to abolish AF with radiofrequency or
ce-cooled catheter ablation techniques, of which the design and landmarks fre-
uently mimic those of the maze III surgery, are improving.2,13,14 Until now it 
nclear how to identify patients with AF who most profit from the various non-
harmacologic AF therapies. Thus far, patients treated with catheter ablation have
redominantly paroxysmal AF (PAF). Despite the absence of associated cardiac
he Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 6 1433
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A
CDisease, smaller left atria, and shorter follow-up, the success
ate cannot match that of maze surgery.
Our 10-year experience with maze III surgery enabled us
o determine whether the initially favorable effects of this
urgery continue in the long term. For this reason we
erformed a single-center outcome study to define the pre-
ictors of long-term AF suppression and to evaluate the
aintenance of normal sinus node function and freedom
rom other supraventricular arrhythmias.
aterials and Methods
nclusion for Maze Surgery
atients with symptomatic PAF or chronic AF (CAF) were offered
aze III surgery. AF was classified as paroxysmal if spontaneous
pisodes of sinus rhythm intervened with bouts of AF. AF without
ocumented sinus rhythm for more than 1 week was classified as
AF. The classification of persistent and permanent AF could not
e applied because this surgery was first performed in 1993,
hereas the AF classification was established later.15 In the lon
F group, failure of more than 3 antiarrhythmic drugs and more
han 1 attempted DC cardioversion were required before accep-
ance for surgery. In the concomitant AF group, these criteria were
ot a prerequisite for cardiac surgery. Reasons to exclude patients
rom maze surgery were documented incompetent sinus nod12
A diameter greater than 90 mm,16 impaired left and/or righ
entricular function,17 and calcified LA wall. Previous failed -
iofrequency catheter ablation of the atria to eradicate AF was no
eason to exclude a patient from maze surgery. Verbal consent for
urgery was obtained after extensive oral information about the
urgery and its alternatives was given.
reoperative Studies
he years of presence of PAF or CAF were determined. The
umber of failed antiarrhythmic drugs and DC cardioversions were
oted. Standard electrocardiogram, 2-channel Holter recordings,
nd bicycle stress testing were used to document AF and to
xclude sinus node disease and abnormal cardiac conduction.
wo-dimensional and pulsed-wave Doppler echocardiographic
tudies were performed to measure cardiac chamber size and
unction and to diagnose structural cardiac disease. Left and right-
ided heart catheterization and coronary angiographies were per-
Abbreviations and Acronyms
AF  atrial fibrillation
AFL  atrial flutter
AV  atrioventricular
CAF  chronic atrial fibrillation
CL  confidence limit
CVA cerebrovascular accident
LA  left atrial
OR  odds ratio
PAF  paroxysmal atrial fibrillation
RA  right atrialormed to identify abnormalities. w
434 The Journal of Thoracic and Cardiovascular Surgery ● Decurgical Procedure
he maze III operation was carried out as described in the initial
eports18 and as mentioned before by our group (Figure 1).12
ostoperative Methods
ntiarrhythmic drugs were administered if AF persisted more than
2 hours. Electrical cardioversion was carried out if antiarrhythmic
rugs failed. The temporary epicardial pacemaker wires served to
ace in case of bradycardia, to diagnose postoperative arrhythmias
nd, in subgroups, to attempt to induce AF. If sinus node function
ailed after more than 14 days postsurgery, a rate-responsive
trioventricular (AV) pacemaker was implanted.
ollow-up Studies
he majority of patients who underwent surgery for lone AF were
ollowed at our own outpatient department at 6 weeks, 3 and 6
onths, and then annually. Patients were asked about palpitations,
ymptoms of cerebrovascular accidents (CVAs), and daily lifestyle
nd exercise tolerance. Holter monitoring and bicycle stress test-
ng19 were performed (systematically at our own institution 
pproximately half of the series and sporadically at other institu-
ions) to detect atrial arrhythmias and sinus node incompetence.
chocardiographic studies were performed. Most of the patients
igure 1. Unmodified maze III procedure. A, Incisions on the right
trium. Amputation of the right auricle and from this opening 2
erpendicular incisions, 1 in the free wall and 1 toward the
ricuspid annulus, where a cryolesion is placed at the annulus. A
ongitudinal atriotomy lateral in the superior caval vein extends
o the inferior caval vein. A perpendicular incision from the
ongitudinal incision to the tricuspid annulus, where a second
ryolesion is placed. An incision is placed in the septum. B,
ncisions on the left atrium. Amputation of the left auricle. The
ulmonary veins are separated from the remainder to the heart in
button. Two connecting lesions from the button are made: 1 to
he left auricle and 1 to the mitral valve. One cryolesion is placed
t the mitral annulus and one at the coronary sinus, which is
xposed through this last incision.ho underwent surgery for concomitant AF were followed by the
ember 2006
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CDeferring cardiologist, who was responsible for the timing and
xaminations of the follow-up.
ollection of Data
he inpatient and outpatient clinic files were searched for baseline,
-year follow-up, and end of follow-up data. If data were incom-
lete, questions about follow-up were mailed to the referring
ardiologist for the completion of latest follow-up data. If the
nvestigators were not able to procure recent or complete informa-
ion, the general practitioner was also consulted. As a last resort,
he patients were contacted by phone. This was the case for only
patients. For the patients who most recently underwent opera-
ion, we only accepted a follow-up of at least 6 months. Follow-up
as gathered from December 1, 2003, to March 31, 2004.
ariables Studied During Follow-up
he time and reason of death were noted. Rhythm was documented
t every contact with the patient. Echocardiographic data were
xamined at 1 year and at the end of follow-up, including LA
iameter (long axis) in the parasternal view, largest RA diameter,
rade of mitral valve regurgitation, and left ventricular ejection
raction. The reason for pacemaker implantation and occurrence of
VA and transient ischemic attack were noted. The use of oral
nticoagulation and antiarrhythmic drugs was studied. Antiar-
hythmic drugs included all beta-blockers and calcium antagonists
rescribed as antihypertensive treatment but with a possible heart
ate-slowing effect. Postoperative occurrence of congestive heart
ailure, onset of valvular pathology, and DC cardioversion were
oted.
efinitions
ll foramen ovale or atrial septal defect closures without a patch
ere considered to be found coincidentally and categorized as
lone AF surgery.” All atrial septal defects requiring a patch were
onsidered to be a separate cardiac abnormality and qualified as
concomitant AF surgery.”
A regular atrial rhythm less than 100 beats/min at rest was
abeled as normal sinus rhythm. Whenever AF occurred, the pa-
ient was categorized as having AF. All runs of 3 or more atrial
eats were categorized as supraventricular tachycardia.
Success was labeled as the absence of symptomatic or asymp-
omatic AF, atrial flutter (AFL), and other atrial tachyarrhythmias
ore than 6 months after surgery. Implantation of a pacemaker for
ncompetent sinus node function or AV block did not rule out
success.”
Failure was defined as symptomatic or asymptomatic AF, AFL,
nd other atrial tachyarrhythmias occurring more than 6 months
fter surgery. Pacing after His bundle ablation for intractable atrial
rrhythmias was also categorized as a failure.
tatistical Analysis
ll values are expressed as mean  standard deviation. For hy-
othesis testing in categoric variables, the Fisher exact test was
sed. For normally distributed data, a paired or an unpaired t test
as used. Non-normally distributed data were compared by the
ann-Whitney U test. Kaplan-Meier curves for freedom from AF
ould not be constructed because the precise time of AF recurrence
fter the operation could often not be determined. A multivariate t
The Journal of Thoracicnalysis was carried out with the use of logistic regression to
etermine factors influencing surgical success (see definition)
ore than 1 year after surgery. The following factors were con-
idered: age, type of preoperative AF, preoperative duration of AF
onger or less than 5 years, preoperative CVA or transient ischemic
ttack, history of preoperative radiofrequency ablation, concomi-
ant procedure or not, aortic crossclamp and cardiopulmonary
ypass time, and highest degree of postoperative AV block. All
alculations were performed with SAS v 8.2 (SAS Inc, Cary, NC).
esults
reoperative Data
etween June 1993 and June 2003, 203 consecutive patients
nderwent the unmodified maze III operation: 139 for lone
F and 64 for a concomitant procedure. AF caused a mean
f 2.5 symptoms before surgery; the most frequent symp-
oms in the lone group were palpitations (83.2%), fatigue
46.0%), dyspnea on exertion (33.6%), vertigo (20.4%),
hest pain (18.2%), syncope (8.0%), and decreased exertion
apacity (8.0%). In the concomitant group, symptoms were
ard to attribute specifically to AF because of the associated
athology. Five patients in the concomitant group experi-
nced congestive heart failure preoperatively. In the lone
F group, male gender dominated, and patients were
ounger, had more PAF, and showed smaller atrial dimen-
ions than the concomitant AF group (Table 1). The 
ion of AF could be determined more accurately in the lone
roup and is probably underestimated in the concomitant
F group. The high number of different antiarrhythmic
rugs tried and the number of failed catheter ablations and
C cardioversions performed reflect the large effort to
revent and treat AF in the lone AF group (Table 1)
erioperative Data
s expected, the duration of extracorporeal circulation and
rossclamp time were considerably longer in patients with
oncomitant surgery (Table 2). In the lone AF grou
trial septal defects/foramen ovale were closed, and 1
trumectomy and 1 open lung biopsy were performed. In 64
atients in whom surgery was combined with the maze
peration, 77 procedures were carried out, including 27
itral valve replacements, 24 mitral valve repairs, 10 cor-
nary artery bypass grafts, 6 tricuspid valve repairs, 8 atrial
eptal defect closures, 1 aortic valve replacement, and 1
ransection of a Kent bundle for Wolff-Parkinson-White
yndrome. There was no difference in postoperative AV
lock, grading of the AV block, and incidence of temporary
acing between the 2 groups (Table 2).
There was no 30-day mortality. In 33 patients of the lone
F group, 46 in-hospital complications were identified:
amponade in 5%; fever of unknown origin, congestive
eart failure, and pneumonia in 4.6% each; and pneumo-
horax, lung atelectasis, bleeding and rethoracotomy, uri-
and Cardiovascular Surgery ● Volume 132, Number 6 1435
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A
CDary retention, and pleural effusion in 1.4% each. In the
oncomitant group 30 patients experienced 33 postoperative
omplications: tamponade in 7.7%; bronchitis/pneumonia in
ABLE 2. Perioperative data
Lone AF
uration of ECC (No. of patients) (
Mean (minutes) 114
Minimum
Maximum 1
uration of aortic crossclamp (No. of patients) (
Mean (minutes) 61
Minimum
Maximum 1
o. of additional flutter treatments 3 (
ransient in-hospital AV block (No. of patients) (
1 28 (
2 11 (
3 1 (
Total 16 (
atients requiring pacing (No. of patients) (
Temporary 69 (
Definitive 2 (
Total 71 (
uration of hospital stay (d)
Median 9.0
ABLE 1. Baseline characteristics of 203 patients treated
ale/female (%)
ean age (y)
uration of AF (No. of patients)
Mean (months)
Minimum
Maximum
ype of AF (No. of patients)
Paroxysmal
Chronic
A diameter (No. of patients)
Mean (mm)
Minimum
Maximum
A diameter (No. of patients)
Mean (mm)
Minimum
Maximum
reoperative CVA
reoperative TIA
ntiarrhythmic drugs (No. of patients)
rugs per patient
o. of patients with previous 1 or more treatments for arrhythmia
ean No. of preoperative electrical cardioversions
VA, cerebrovascular accident; TIA, transient ischemic attack; AF, atrialCC, Extracorporeal circulation; AV, atrioventricular.
436 The Journal of Thoracic and Cardiovascular Surgery ● Dec.7%; bleeding and rethoracotomy in 4.6%; transient periph-
ral neurologic deficit in 4.6%; and congestive heart failure,
rinary tract infection, permanent neurologic deficit, and atel-
68%) Concomitant procedures 64 (32%) P value
(63)
.5 148 30.6 .0001
84
259
(63)
.1 90 22.5 .0001
60
150
0 .553
(64)
) 19 (29.2%)
8 (12.3)
3 (4.6)
) 8 (12.3) .214
(64)
) 31 (48.4%)
1 (1.6%)
) 32 (50%) .763
10.0  5.3 .001
maze III surgery
Lone AF 139 (68%) Concomitant procedures 64 (32%) P value
85.6/14.4 65.6/34.4 .003
50.7 8.1 58.1 10.9 .0001
(139) (56)
84 60.7 51 49.8 .001
8 2
360 216
(139) (63)
108 (77.7%) 34 (53.1%) .001
31 (22.3%) 30 (46.9%)
(124) (57)
41.9 7.6 51.7 9.8 .001
28 35
68 74
(90) (12)
53.0 6.1 57.0 6.9 .04
38 44
70 64
3 (2.2%) 2 (3.1%) .65
7 (5.0%) 3 (4.7%) 1
(132) (62)
4.9 1.7 2.5 1.6 .001
22 (15.8%) 3 (4.6%) .023
3.0 1.2 .002
tion; LA, left atrial; RA, right atrial.139 (
136)
 18
76
82
136)
 18
37
49
2.2%)
135)
20.5%
8.1%)
0.7%)
11.9%
139)
49.6%
1.4%)
51.1%
 4.0with
fibrillaember 2006
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CDctasis in 3.1% of the patients. In 1 patient the right coronary
rtery located in the wall of the RA was damaged, which was
epaired with a venous bypass graft.
ollow-up Observations
ata were complete in 84.7% for the 1-year follow-up and
n 97% for the latest follow-up. The total follow-up time
as 796 patient years with a mean of 4.0  2.6 years per
atient.
Twelve patients (5.9%) died during follow-up, 1 because
f colon carcinoma in the lone AF group (0.7%). Two of the
ther 11 deaths (17.2%) in the concomitant AF group were
ttributable to cardiac complications: asystole (1) and ven-
ricular fibrillation (1). The remainder were attributable to
arcinoma (4), cerebral sarcoidosis (1), CVA (1), dementia
igure 2. Rhythms at the end of follow-up. FU, Follow-up; PMAF,
trial fibrillation and pacemaker; chron AF, chronic atrial fibril-
ation; SVT, supraventricular tachycardia; AFL, atrial flutter; PAF,
aroxysmal atrial fibrillation; PmfreeAF, freedom from atrial fi-
rillation with pacemaker implanted; SR, sinus rhythm; AF, atrial
brillation.1), and unknown cause (2). a
The Journal of Thoracichythm Results
he rhythms at the end of follow-up are depicted in
igure 2. Freedom from AF at the latest follow-up 
9.7% for the lone AF group and 69.4% for the concom-
tant group. By applying our definition of success, free-
om from any atrial arrhythmia was 77.7% and 76.9% at
year and 80.1% and 64.5% at the latest follow-up for
he lone AF group and the concomitant AF group, re-
pectively (Figure 3). In the lone AF group, 41.1% of t
atients with supraventricular arrhythmias were free from
alpitations; this was 30.0% in the concomitant AF group.
uring follow-up, transcutaneous catheter ablation was car-
ied out in 3 patients for recurrent drug-refractory AF but
as successful in only 1 patient. In the remaining 2 patients,
rug treatment was continued with other combinations.
For the whole group, multivariate analysis revealed that
1) surgical success (see definition) at the end of follow-up
as strongly related to the absence of AF at 1 year after
urgery (P  .001; odds ratio [OR] 9.56, 95% confidence
imit (CL) 3.92-23.31); (2) preoperative LA diameter cor-
elated with the occurrence of AF at the end of follow-up
P  .028; OR 1.06 for every millimeter, 95% CL 1.01-
.12); and (3) failure at 1-year follow-up was related to the
reoperative duration of AF of more than 5 years (P .066;
R  2.06, 95% CL: 0.95-4.46). No correlation was found
etween the preoperative duration of AF and the latest
ollow-up results.
We could not demonstrate a significant (P  .05) differ-
nce of success between the lone AF group and the con-
omitant AF group.
Of the patients with surgical success, freedom from antiar-
hythmic medication at the latest follow-up was 75.9% in the
one group and 63.2% in the concomitant group. Freedom
rom oral anticoagulants was 90.7% in the lone AF group
igure 3. Surgical success and freedom from AF of the maze III
rocedure at 1 year and end of follow-up. AF, Atrial fibrillation;
U, follow-up.nd 50.9% in the concomitant AF group. Eighty-eight per-
and Cardiovascular Surgery ● Volume 132, Number 6 1437
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CDent of the patients of the concomitant AF group without
echanical valves did not use anticoagulation.
acemaker Implantation
t the latest follow-up, 14 patients (10.4%) in the lone AF
roup and 7 patients (11.1%) in the concomitant group had
pacemaker. Two of the pacemakers in patients of the lone
F group were already implanted before the maze opera-
ion. In the lone AF group, pacemakers were implanted for
ick sinus syndrome (6), for total AV block (2), for brady-
ardia (2), and after His ablation (4). In the concomitant
roup, pacemakers were implanted for sick sinus syndrome
3), for total AV block (1), and after His ablation (3).
troke
n the lone AF group, no CVA occurred during follow-up.
n the concomitant AF group, 2 patients had a CVA. One
atient had an intracerebral bleed attributable to an elevated
nternational normalized ratio (5.7); he used oral anticoagu-
ants for a mechanical valve in the mitral position. The other
atient had an embolic stroke while using oral anticoagu-
ants after mitral valve repair. Both patients were in sinus
hythm.
inus Node Function
ne half of the patients in the lone AF group (63/139)
nderwent maximal heart rate exercise testing during
ollow-up in the appropriate condition: no heart-slowing
edication and not in AF or other atrial tachyarrhythmias.
he mean maximal heart rate was 90%  3% of the pre-
ABLE 3. Echocardiographic data
Baseline
n Average  SD
one AF
LA (mm) 124 41.9  7.5
RA (mm) 90 53.6  6.1
oncomitant AF
LA (mm) 57 51.7  9.8
RA (mm) 15 56.7  6.9
F in lone AF
EF (%)
F in concomitant AF
EF (%)
I in lone AF
I (n/4)
I in concomitant AF
I (grade 0-4)
D, Standard deviation; AF, atrial fibrillation; LA, left atrial; RA, right atriaicted value. In the concomitant AF group, 23 patients 6
438 The Journal of Thoracic and Cardiovascular Surgery ● Deculfilled these criteria, and the mean of the maximal heart
ate was 91%  11% of predicted.
chocardiography
chocardiography showed a significant reduction of the
A dimensions in both groups at 1-year follow-up com-
ared with baseline characteristics, but the dimensions
ncreased again afterward (Table 3). The mitral regu
ation in the lone AF group increased significantly during
ollow-up and increased nonsignificantly in the concom-
tant AF group.
iscussion
uccess was defined as freedom from AF, AFL, and other
upraventricular arrhythmias. According to our definition,
he cumulative medium-term freedom from these arrhyth-
ias can be determined by the preoperative LA diameter.
he success at the end of follow-up can be predicted at 1
ear after the operation. This observation indicates that
uccess persists during follow-up and depends on the pre-
perative LA diameter. Other clinical risk factors could not
e determined. The duration of preoperative AF signifi-
antly influenced only the 1-year results. The absence of a
ignificant correlation with success at the end of follow-up
ay be attributable to a lack of power. Our definition of
uccess, determined by the absence of all atrial arrhythmias,
ecause they all affect the patient, deviates strongly from
uccess criteria used by others. If we use freedom from AF,
s many authors do, our success is 89.7% for lone AF and
1 year End
Average  SD n Average  SD
.0413
3 40.7 6.8 64 40.8 8.8
3 50.6 6.1 47 53.5 6.5
.0001
3 44.3 7.3 40 48.8 10.1
9 51.0 8.8 28 54.0 9.3
1 55.3 11.0 60 57.0 9.6
8 53.3 8.4 33 50.9 10.9
P  .0001
1 0.3 0.5 66 0.5 0.6
1 0.4 0.8 45 0.4 0.6
ejection fraction; MI, mitral incompetence.n
P 
7
7
P 
4
3
7
3
7
49.4% for concomitant AF at the end of follow-up.
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CDifferences in Success
ultivariate regression analysis did not show a significant
ifference in success between the 2 groups. The differences
f success at the end of follow-up were attributable to
aseline differences, especially LA diameters (Table 
reoperative LA diameters were larger in the concomitant
roup, reflecting a more extensive cardiac disease process,
n part because of the high incidence of mitral valve disease.
correlation between LA dimension and long-term results
as clearly been identified by others.3 The absence of 
ignificant difference between the lone and concomitant AF
roups was also identified by others.4
Our data show a significant decrease in LA diameter as
result of the operation, partly because of the suture line
nd partly because of the treatment of mitral valve pathol-
gy. Although not significant, there is a larger increase in
trial diameters of the concomitant AF group during
ollow-up as a consequence of more degenerated substrate
nd more progressed disease. Recent evidence demonstrates
hat aggressively reducing the size of giant left atria can
ositively influence the success.20 No atrial size reductio
as performed in our patients.
revious Publications
ur success is similar to that of other large series,3,5,7 but
eems to be inferior to others.4 A reason could be t
pplication of a cryolesion only at the inside of the coronary
inus instead of circumferentially.21 Five patients had 
eft-sided flutter during follow-up catheter mapping. How-
ver, the main reason for the difference in reported results is
aused by our strict definition of success and the rigorous
ocumentation of supraventricular arrhythmias. 22,23 Whereas
ost authors define success as freedom from only AF, we
sed a more strict definition of success. After all, many
atients free from AF still have tachycardia. In contrast with
ther authors,4,8 we did not rely on subjective patient in-
ation obtained by phone contact. Up to 41% of our pa-
ients with postoperative AF had no palpitations. The oc-
urrence of asymptomatic episodes of supraventricular
achycardias, even in patients who have had symptomatic
pisodes before, was already proven.24
n-Hospital and Late Survival
o 30-day mortality was present in our series, and the
ardiac death rate during follow-up was minimal (1%),
hich may be explained by the fact that the patients in the
one AF group were young and fit with little comorbidity.
espite the complexity of the operation, mortality and mor-
idity are minimal in most large series.
ntiarrhythmic Drugs
he freedom from antiarrhythmic drugs is low because
any patients used beta-blocking agents, digoxin, or cal-ium antagonists for reasons other than suppression or pre- f
The Journal of Thoracicention of AF and supraventricular arrhythmias. The per-
entage of patients receiving antiarrhythmic drugs is in line
ith other groups.5
acemaker
he incidence of postoperative pacemaker implantation is in
he range of what other authors found, notwithstanding the
act that normal sinus node function was requested for
urgery. Incidences up to 16% can be found.8 Could exten-
ive mobilization of the superior caval vein, and thus dam-
ge to the sinus node region, play a role or have we failed
o document sick sinus syndrome preoperatively in a few
atients? Abolition of AF, but with an implanted pace-
aker, does not necessarily mean a failure because atrial
ransport can be maintained, and antiarrhythmic drugs and
ral anticoagulants can be withdrawn.
troke
n recent years it has become clear that the maze operation
s also highly successful in the prevention of ischemic
VA,5,25 which was also the case in our series.
omparison With Modified Maze Operations
ecause of the complexity and duration of classic maze III
urgery, many attempted to simplify the design and appli-
ation of the original concept.26-28 Until now it has be
nclear whether these therapies are as efficacious as the full
aze procedure. To our knowledge, no randomized studies
ave been published comparing the full cut-and-sew maze
rocedure with operations with a more simple lesion pattern
r using other energy devices. A recent review found no
ifference.29
ndications for Surgical Treatment of Atrial
ibrillation
ur current strategy is to offer maze surgery to symptomatic
atients with lone AF if antiarrhythmic drugs, cardiover-
ions, and percutaneous catheter ablation failed or AF and
FL coexist; the latter because catheter ablation of both
rrhythmias will require lengthy procedures with a long
xposure to radiation.
For patients with concomitant AF, the threshold is lower
or performing an additional maze procedure to treat AF
ecause of the severe consequences of AF. In the future,
blation devices will simplify the creation of lesions in atrial
yocardium. Most patients undergoing a concomitant pro-
edure can benefit from AF surgery, especially patients in
hom oral anticoagulants can be withdrawn and the surgi-
al risk is acceptable.
tudy Limitations
he definitions applied for surgical success are not widely
sed because of a lack of consensus.22,23 This complicates 
air comparison of the surgical success with that of other
and Cardiovascular Surgery ● Volume 132, Number 6 1439
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Surgery for Acquired Cardiovascular Disease Ballaux et al
1
A
CDnstitutions. Lack of intensive and long duration electrocar-
iographic recordings of the cardiac rhythm, because these
egistrations could negatively influence the result of the
tudy.
onclusions
his study shows that the favorable unmodified maze III
esults of abolishment of AF and other atrial arrhythmias in
atients with and without additional cardiac surgery persist
or at least 4 years after surgery and can be predicted at the
nd of the first year after maze surgery. This outcome can be
sed for preoperative patient information and postoperative
trategy of patient care.
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